Advancing the realization of oral insulin using novel peptide technology

For more than a century, oral insulin has been considered a “dream” therapy for diabetes, hindered by enzymatic degradation in the digestive tract and the absence of a dedicated intestinal transport mechanism. Consequently, many patients must…

Continue Reading

News Source: medicalxpress.com